News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Dr. Mahmoud Ould-Kaci speaking about oncology drug portfolio at Boehringer Ingelheim at AACR24
Photo of Mahmoud Ould-Kaci taken from Wafik S. El-Deiry/LinkedIn
Apr 6, 2024, 08:28

Dr. Mahmoud Ould-Kaci speaking about oncology drug portfolio at Boehringer Ingelheim at AACR24

Wafik S. El-Deiry, 

“Listening to Dr. Mahmoud Ould-Kaci who is speaking about oncology drug portfolio at Boehringer Ingelheim at AACR24.”

Image

Source: Wafik S. El-Deiry/X

AACR 2024 Annual Meeting AACR24 American Association for Cancer Research Boehringer Ingelheim Brown University cancer Legorreta Cancer Center Mahmoud Ould-Kaci OncoDaily Oncology Wafik S. El-Deiry
Special Coverage
Blog
Nov 13, 2024, 15:29
Showcase Event for smartCARE and Protect-Europe EU Co-Funded Projects
Blog
Nov 13, 2024, 15:25
ESMO Immuno - Oncology Annual Congress 2024
Blog
Nov 13, 2024, 15:07
Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development
Blog
Nov 13, 2024, 14:55
Krish Patel has been appointed as the New Director of Lymphoma Research at SCRI
Blog
Nov 13, 2024, 14:49
Carmen Monge-Montero: Overcoming Cancer Without Discrimination - Opinion piece with Luis Fernando Solís Calvo
Blog
Nov 13, 2024, 14:47
Laura Samá: Don’t miss our posters at CTOS2024
Blog
Nov 13, 2024, 14:43
How climate change disrupts cancer services and threatens progress - UICC
Blog
Nov 13, 2024, 14:37
Don't miss out on the 2025 ASCO Voices session
Blog
Nov 13, 2024, 14:37
Help young people like Eric spread awareness and advocate for more research - Oncogene Cancer Research
Blog
Nov 13, 2024, 14:05
Tala Mahmoud: Honored to be selected as Reviewer of the Month by ACGCRJ
Blog
Nov 13, 2024, 12:13
Sarah Briggs: Cancer control in the face of climate change
Blog
Nov 13, 2024, 11:56
HER2-Low Status and Its Impact on Outcomes in Early-Stage Triple-Negative Breast Cancer